Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Pharmacological Research|March 5, 2004
Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritisJae Youl Cho, Joon Seok Park, Kyong Up Baik, et al.
Archives of Pharmacal Research|August 13, 2016
Synthesis and sar studies for the inhibition of tnf-α production. part 2. 2-[3-(cyclopentyloxy)-4-methoxyphenyl]-substituted-1 -isoindolinone derivativesJoon Seok Park, Seong Cheol Moon, Kyung Up Baik, et al.
Journal of Obesity & Metabolic Syndrome|October 5, 2019
Food Craving, Seeking, and Consumption Behaviors: Conceptual Phases and Assessment Methods Used in Animal and Human StudiesYoung Hee Lee, Meelim Kim, Miwoo Lee, et al.
The Journal of Pharmacy and Pharmacology|April 22, 2004
Effects of dialkoxylphenyl compounds with oxime group on macrophage function and the proliferation of lymphocytesEun Sook Yoo, Ho Jung Son, Joon Seok Park, et al.
The British Journal of Dermatology|April 15, 2025
Prolyl-tRNA synthetase inhibitor as a novel first-in-class keloid treatment: Downregulation of de novo collagen synthesis and inflammatory cascadeSally Min, Ki-Myo Kim, Joseph Hwang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2012
Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligandEmily Corse, Rachel A Gottschalk, Joon Seok Park, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 24, 2025
Reverse translational approach to clarify the strong potency of enavogliflozin, a novel sodium-glucose cotransporter 2 inhibitorSun-Hwa Park, Hye-Young Ji, Ji-Soo Choi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 24, 2025
Restoration of intestinal barrier function by fexuprazan, a potassium-competitive acid blocker, in Caco-2 cells and its higher gastrointestinal distribution in ratsJi-Hyeon Jeon, Jihoon Lee, Yeon-Ju Baek, et al.
Science Translational Medicine|March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapyDmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
Archives of Pharmacal Research|May 15, 2002
Synthesis and SAR studies for the inhibition of TNF-alpha production. Part 2. 2-[3-(Cyclopentyloxy)-4-methoxyphenyl]-substituted-1-isoindolinone derivativesJoon Seok Park, Seong Cheol Moon, Kyong Up Baik, et al.
Pageof 6